Table 3.
Summary of the visits
| Patients | Blood collection | Adverse events | Concomitant treatment | Drop off | |
|---|---|---|---|---|---|
| V1 |
22 |
22 |
- |
- |
- |
| V2 |
22 |
|
9.1% |
50.0% |
|
| (7 days) | |||||
| V3 |
22 |
22 |
14.3% |
45.4% |
1 |
| (14 days) | |||||
| V4 |
21 |
|
14.3% |
35.0% |
1 |
| (28 days) | |||||
| V5 (84 days) |
20 | 20 | 25% | 55.6% |
V1: first visit, at the time of selection; V2: visit after 7 days of treatment ; V3: visit after 14 days of treatment; V4: visit after 28 days of treatment; V5: visit after 84 days of treatment.
Knee OA patients with night pain and effusion were asked to take 2x3 caps of an enriched curcumin extract twice a day for 3 months from V1. They were visited after 7, 14, 28 and 84 days of treatment.